Stockle - the stock oracle

Apotheca Biosciences, Inc.

US:PCFPUS:CBDC
No current share price held for this company.

Past year: ▼ 98%(0.01c – 7.00c USD)

Market cap
—
Shares on issue
—
Story beats
14 since 2017
Last event
27 June 2019

Announcements, explained

Each one in plain English, with the numbers worked through for a shareholder.

22 June 2017bylaws amendment● NeutralMajor

Renamed itself Cannabis Leaf Incorporated by merging a shell subsidiary of that name into itself - a paperwork device that needed no shareholder vote - and at the same time multiplied its shares six-for-one and raised its authorised capital. The mineral-exploration identity was formally dropped for a cannabis one.

Discuss in chat

21 June 2017quarterly activities report▼ Bad

Apotheca Biosciences, Inc. reported a quarterly net loss of $5 thousand for the period ended 2017-04-30.

Discuss in chat

15 June 2017late filing notice▼ Bad

Apotheca Biosciences, Inc. notified the SEC that its quarterly report would be filed late.

Discuss in chat

9 May 2017material agreement● NeutralMajor

Converted the March letter of intent into a definitive exclusive licence with Affordable Green Washington, due $25,000 on signing, $100,000 by end of May and $2 million by 30 September 2017. Director Wan Soo Lee resigned the same day.

Discuss in chat

1 May 2017late filing notice▼ Bad

Apotheca Biosciences, Inc. notified the SEC that its annual report would be filed late.

Discuss in chat

4 Apr 2017material agreement● NeutralMajor

Pacificorp Holdings - a Nevada shell incorporated in 2014 to explore mineral properties, with no mining ever done - signed a letter of intent to license Affordable Green Washington's marijuana products and marketing model for Washington State, promising $2.1 million in stages. The first move in a three-year hunt for a business to be in.

Discuss in chat

20 Dec 2016quarterly activities report▼ Bad

Apotheca Biosciences, Inc. reported a quarterly net loss of $4 thousand for the period ended 2016-10-31.

Discuss in chat

16 Dec 2016late filing notice▼ Bad

Apotheca Biosciences, Inc. notified the SEC that its quarterly report would be filed late.

Discuss in chat

2 Sept 2016quarterly activities report▼ Bad

Apotheca Biosciences, Inc. reported a quarterly net loss of $5 thousand for the period ended 2016-07-31.

Discuss in chat

20 June 2016quarterly activities report▼ Bad

Apotheca Biosciences, Inc. reported a quarterly net loss of $5 thousand for the period ended 2016-04-30.

Discuss in chat

14 June 2016late filing notice▼ Bad

Apotheca Biosciences, Inc. notified the SEC that its quarterly report would be filed late.

Discuss in chat

2 May 2016late filing notice▼ Bad

Apotheca Biosciences, Inc. notified the SEC that its annual report would be filed late.

Discuss in chat

14 Dec 2015quarterly activities report▼ Bad

Apotheca Biosciences, Inc. reported a quarterly net loss of $17 thousand for the period ended 2015-10-31.

Discuss in chat

14 Sept 2015quarterly activities report▼ Bad

Apotheca Biosciences, Inc. reported a quarterly net loss of $6 thousand for the period ended 2015-07-31.

Discuss in chat

10 July 2015securities registration● Neutral

Apotheca Biosciences, Inc. filed the final prospectus for a registered offering.

Discuss in chat

29 June 2015securities registration● Neutral

Apotheca Biosciences, Inc. amended a filing by which it registered a securities offering with the SEC.

Discuss in chat

5 June 2015securities registration● Neutral

Apotheca Biosciences, Inc. amended a filing by which it registered a securities offering with the SEC.

Discuss in chat

26 May 2015securities registration● Neutral

Apotheca Biosciences, Inc. amended a filing by which it registered a securities offering with the SEC.

Discuss in chat

21 Apr 2015securities registration● Neutral

Apotheca Biosciences, Inc. registered a securities offering with the SEC.

Discuss in chat